Drug Trial Radar · NCT00301236
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
Last checked: Nov 19, 2026Latest source record: Dec 21, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
252
Actual
Start
Feb 2006
Primary completion
Not stated
Study completion Nov 2006
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 10, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 12 years
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
Conditions
- ADHD, ADD
Interventions
Dexmethylphenidate HCl extended-release capsulesDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of the symptoms by the patient's teacher after 5 weeks of treatment.
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Novartis Investigational Site
Mesa, Arizona
Novartis Investigational Site
Little Rock, Arkansas
Novartis Investigational Site
Los Angeles, California
Novartis Investigational Site
Boulder, Colorado
Novartis Investigational Site
Maitland, Florida
Novartis Investigational Site
Orlando, Florida
Novartis Investigational Site
Stone Mountain, Georgia
Novartis Investigational Site
Libertyville, Illinois
Novartis Investigational Site
Overland Park, Kansas
Novartis Investigational Site
Prairie Village, Kansas
Novartis Investigational Site
Cambridge, Massachusetts
Novartis Investigational Site
Las Vegas, Nevada
Novartis Investigational Site
Piscataway, New Jersey
Novartis Investigational Site
Toms River, New Jersey
Novartis Investigational Site
New York, New York
Novartis Investigational Site
New York, New York
Novartis Investigational Site
Staten Island, New York
Novartis Investigational Site
Chapel Hill, North Carolina
Novartis Investigational Site
Raleigh, North Carolina
Novartis Investigational Site
Columbus, Ohio
Novartis Investigational Site
Gresham, Oregon
Novartis Investigational Site
Philadelphia, Pennsylvania
Novartis Investigational Site
Jackson, Tennessee
Novartis Investigational Site
Memphis, Tennessee
Novartis Investigational Site
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.